logo

Last Update

This profile was last updated on 7/15/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong ReGen Biologics?

ReGen Biologics

Director of Clinical Affairs

Howmedica , Inc.

HQ Phone:  (201) 831-5000

Email: r***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Howmedica , Inc.

325 Corporate Drive

Mahwah, New Jersey,07430

United States

Company Description

Howmedica Osteonics Corporation is the orthopaedic implant manufacturing subsidiary of surgical and medical product leader Stryker ® Corporation. Howmedica Osteonics develops, manufactures, and markets orthopaedic reconstructive products, such as hip, knee, u...more

Web References(140 Total References)


Management Team | Ivy Sports Medicine

www.ivysportsmed.com [cached]

Before joining ReGen, he was Director of Clinical Affairs at Howmedica Osteonics, Inc. where he was responsible for the integration of the clinical departments of both companies after the acquisition by Stryker, Inc.
Prior to that time, he worked for the Howmedica Division of Pfizer Medical Technology from 1984 to 1998 in a series of increasingly responsible positions in Research and Development and Regulatory Affairs. As Director of Regulatory Affairs and Public Policy, he was responsible for worldwide regulatory approvals for Howmedica's orthopaedic, craniomaxillofacial and neurological products. He holds a B.A. in biological science from Columbia College.


Management Team | Ivy Sports Medicine

www.ivysportsmed.com [cached]

Before joining ReGen, he was Director of Clinical Affairs at Howmedica Osteonics, Inc. where he was responsible for the integration of the clinical departments of both companies after the acquisition by Stryker, Inc.
Prior to that time, he worked for the Howmedica Division of Pfizer Medical Technology from 1984 to 1998 in a series of increasingly responsible positions in Research and Development and Regulatory Affairs. As Director of Regulatory Affairs and Public Policy, he was responsible for worldwide regulatory approvals for Howmedica's orthopaedic, craniomaxillofacial and neurological products. He holds a B.A. in biological science from Columbia College. Mr. Bailey has worked in and run sales organizations focusing in Sports Medicine, Biologics, Joint Replacement and Spinal Implants.


Management Team | Ivy Sports Medicine

www.ivysportsmed.com [cached]

Before joining ReGen, he was Director of Clinical Affairs at Howmedica Osteonics, Inc. where he was responsible for the integration of the clinical departments of both companies after the acquisition by Stryker, Inc.
Prior to that time, he worked for the Howmedica Division of Pfizer Medical Technology from 1984 to 1998 in a series of increasingly responsible positions in Research and Development and Regulatory Affairs. As Director of Regulatory Affairs and Public Policy, he was responsible for worldwide regulatory approvals for Howmedica's orthopaedic, craniomaxillofacial and neurological products. He holds a B.A. in biological science from Columbia College.


Management Team | Orthopedic Products Company | ReGen Biologics

www.regenbio.com [cached]

Regen Biologics
Gerald Bisbee joined ReGen in 1998. Following sale of the assets of APACHE, Dr. Bisbee became the Chairman of its successor corporation, AROS Corporation, which entered into a reverse merged transaction with ReGen to form ReGen Biologics, Inc. Before joining ReGen, he was Director of Clinical Affairs at Howmedica Osteonics, Inc. where he was responsible for the integration of the clinical departments of both companies after the acquisition by Stryker, Inc. Prior to that time, he worked for the Howmedica Division of Pfizer Medical Technology from 1984 to 1998 in a series of increasingly responsible positions in Research and Development and Regulatory Affairs. As Director of Regulatory Affairs and Public Policy, he was responsible for worldwide regulatory approvals for Howmedica's orthopaedic, craniomaxillofacial and neurological products. He holds a B.A. in biological science from Columbia College. William Rodkey joined ReGen in October 1992. Prior to joining ReGen, Mr. Umidi was the founder and President of Umidi + Company, Inc., which provides professional accounting and financial management services to growing companies.


Investors - Management Team -- ReGen Biologics

www.regenbio.com [cached]

ReGen BiologicsReGen BiologicsGerald Bisbee joined ReGen in 1998.Following sale of the assets of APACHE, Dr. Bisbee became the Chairman of its successor corporation, AROS Corporation, which entered into a reverse merged transaction with ReGen to form ReGen Biologics, Inc.Before joining ReGen, he was Director of Clinical Affairs at Howmedica Osteonics, Inc. where he was responsible for the integration of the clinical departments of both companies after the acquisition by Stryker, Inc.Prior to that time, he worked for the Howmedica Division of Pfizer Medical Technology from 1984 to 1998 in a series of increasingly responsible positions in Research and Development and Regulatory Affairs.As Director of Regulatory Affairs and Public Policy, he was responsible for worldwide regulatory approvals for Howmedica's orthopaedic, craniomaxillofacial and neurological products.He holds a B.A. in biological science from Columbia College. Stephen Harris joined ReGen Biologics in 1998, possessing a strong life science and biomaterials background.William Rodkey joined ReGen in October 1992.Prior to joining ReGen, Mr. Umidi was the founder and President of Umidi + Company, Inc., which provides professional accounting and financial management services to growing companies.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory